Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 study

Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 study Prof Lin Shen, MDa,* Send email to shenlin@bmju.edu.cn ∙ Prof Xiaotian Zhang, MDa,b,* ∙ Ke Ji, MDc,* ∙ Prof Linzhi Lu, MDd,* ∙ Prof Quan Wang, MDe,* ∙ Prof Quanlin Guan, MDf ∙ et al. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00974-8/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_asco26&_hsenc=p2ANqtz-85HEhQUOIH_jiIF3OUcRSKQKZPzARwhO8ugL2s-CVCqeNok5I2LzAiF1xp7wBq4W4Cy40pjUB972ip0AQnPGRfYx_Oow&_hsmi=421795296&utm_content=421795296&utm_source=hs_email